In our analysis of the colon cancer TCGA dataset, we observed that PTX3-high tumors expressed higher levels of the M2 macrophage signature genes and lower levels of the CD8+ T-cell signature genes (Additional file 3: Fig. S6), implying that PTX3 contributes to a protumor immune microenvironment. Here, CD8A is linked to malignant colon neoplasm.